Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to Sell at StockNews.com
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a research note issued to investors on Tuesday. Several other analysts have also issued reports on the company. JPMorgan Chase & Co. lowered their target price on Ionis Pharmaceuticals from $51.00 to $47.00 and set a “neutral” […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a research note issued to investors on Tuesday. Several other analysts have also issued reports on the company. JPMorgan Chase & Co. lowered their target price on Ionis Pharmaceuticals from $51.00 to $47.00 and set a “neutral” […]
